|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
61,398,000 |
Market
Cap: |
314.97(M) |
Last
Volume: |
774,374 |
Avg
Vol: |
701,733 |
52
Week Range: |
$3.38 - $6.66 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 803 |
Guru Rank Value : 1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
121,098 |
121,098 |
148,134 |
388,157 |
Total Sell Value |
$513,345 |
$513,345 |
$684,141 |
$2,735,436 |
Total People Sold |
5 |
5 |
6 |
8 |
Total Sell Transactions |
10 |
10 |
14 |
33 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Leschly Jan |
10% Owner |
|
2006-11-27 |
4 |
S |
$14.18 |
$4,254,000 |
I/I |
(300,000) |
169,726 |
|
- |
|
Ramsay David Russ |
Director |
|
2006-11-27 |
4 |
S |
$14.18 |
$4,254,000 |
I/I |
(300,000) |
0 |
|
- |
|
Karabelas Argeris N |
Chairman of the Board |
|
2006-11-27 |
4 |
S |
$14.18 |
$4,254,000 |
I/I |
(300,000) |
169,726 |
|
- |
|
Karabelas Argeris N |
Chairman of the Board |
|
2006-11-22 |
4 |
S |
$14.12 |
$4,236,000 |
I/I |
(300,000) |
188,986 |
|
- |
|
Ramsay David Russ |
Director |
|
2006-11-22 |
4 |
S |
$14.12 |
$4,236,000 |
I/I |
(300,000) |
188,986 |
|
- |
|
Leschly Jan |
10% Owner |
|
2006-11-22 |
4 |
S |
$14.12 |
$4,236,000 |
I/I |
(300,000) |
188,986 |
|
- |
|
Leschly Jan |
10% Owner |
|
2006-11-21 |
4 |
S |
$14.55 |
$727,500 |
I/I |
(50,000) |
208,246 |
|
- |
|
Ramsay David Russ |
Director |
|
2006-11-21 |
4 |
S |
$14.55 |
$727,500 |
I/I |
(50,000) |
208,246 |
|
- |
|
Karabelas Argeris N |
Chairman of the Board |
|
2006-11-21 |
4 |
S |
$14.55 |
$727,500 |
I/I |
(50,000) |
208,246 |
|
- |
|
Ramsay David Russ |
Director |
|
2006-11-20 |
4 |
S |
$15.29 |
$764,500 |
I/I |
(50,000) |
310,495 |
|
- |
|
Ramsay David Russ |
Director |
|
2006-11-20 |
4/A |
S |
$15.29 |
$764,500 |
I/I |
(50,000) |
211,456 |
|
- |
|
Leschly Jan |
10% Owner |
|
2006-11-20 |
4/A |
S |
$15.29 |
$764,500 |
I/I |
(50,000) |
0 |
|
- |
|
Karabelas Argeris N |
Chairman of the Board |
|
2006-11-20 |
4/A |
S |
$15.29 |
$764,500 |
I/I |
(50,000) |
211,456 |
|
- |
|
Leschly Jan |
10% Owner |
|
2006-11-20 |
4 |
S |
$15.29 |
$764,500 |
I/I |
(50,000) |
310,495 |
|
- |
|
Karabelas Argeris N |
Chairman of the Board |
|
2006-11-20 |
4 |
S |
$15.29 |
$764,500 |
I/I |
(50,000) |
310,495 |
|
- |
|
Edb Investments Pte Ltd. |
10% Owner |
|
2006-11-20 |
4 |
S |
$15.74 |
$786,770 |
I/I |
(50,000) |
2,446,957 |
|
- |
|
Ramsay David Russ |
Director |
|
2006-11-17 |
4 |
S |
$14.25 |
$3,847,500 |
I/I |
(270,000) |
313,705 |
|
- |
|
Ramsay David Russ |
Director |
|
2006-11-17 |
4/A |
S |
$14.25 |
$3,847,500 |
I/I |
(270,000) |
214,666 |
|
- |
|
Leschly Jan |
10% Owner |
|
2006-11-17 |
4/A |
S |
$14.25 |
$3,847,500 |
I/I |
(270,000) |
0 |
|
- |
|
Karabelas Argeris N |
Chairman of the Board |
|
2006-11-17 |
4/A |
S |
$14.25 |
$3,847,500 |
I/I |
(270,000) |
214,666 |
|
- |
|
Leschly Jan |
10% Owner |
|
2006-11-17 |
4 |
S |
$14.25 |
$3,847,500 |
I/I |
(270,000) |
313,705 |
|
- |
|
Karabelas Argeris N |
Chairman of the Board |
|
2006-11-17 |
4 |
S |
$14.25 |
$3,847,500 |
I/I |
(270,000) |
313,705 |
|
- |
|
Edb Investments Pte Ltd. |
10% Owner |
|
2006-11-17 |
4 |
S |
$14.30 |
$715,100 |
I/I |
(50,000) |
2,496,957 |
|
- |
|
Rho Management Trust I |
10% Owner |
|
2006-11-15 |
4 |
S |
$14.96 |
$8,090,236 |
I/I |
(540,000) |
1,862,692 |
|
- |
|
Edb Investments Pte Ltd. |
10% Owner |
|
2006-11-15 |
4 |
S |
$15.13 |
$389,051 |
I/I |
(25,711) |
2,546,957 |
|
- |
|
549 Records found
|
|
Page 20 of 22 |
|
|